Yvonne Greenstreet, Chief Operating Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 57,811 shares at $150.00 ($8.6M) on 2020-05-06, disclosed to the SEC on 2020-05-07.
Open-market sale of $8.6M ALNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.00 | 7,811 | $1.1M | 12.7% |
| 2 | $150.00 | 50,000 | $7.5M | 87.3% |
| Total | $148.65 avg | 57,811 | $8.6M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |